World

Gaza residents suffer from 'manufactured' humanitarian crisis: British doctor

Jul 07, 2024

Tel Aviv [Israel], July 7: Dr James Smith, an emergency physician from the UK who has worked in Gaza's hospital, has told Al Jazeera from London that he saw a "catastrophic and entirely manufactured" humanitarian crisis during his recent trip to the besieged enclave.
He described a large number of displaced people living in "abject" conditions in makeshift tents crammed in a small geographical space with raw sewage flowing in the streets.
"Add in addition to that the complete and intentional decimation of the healthcare system and you have this catastrophic and entirely manufactured crisis as we now see in Gaza," he said.
Dr Smith said that the many of the skin diseases, including scabies and lice infestations, spread on "unprecedented level" in the enclave are relatively easy to treat and to prevent, but "without treatment and without good prevention can lead to catastrophic complications for many patients."
"If Israel was to allow and permit an entry of humanitarian aid, medical aid into Gaza as it is legally obliged to do as the occupying power, then this situation could be very quickly and very easily reversed," he concluded. (Agencies)
Source: Qatar Tribune

More news

A Major Breakthrough in the Diamond Industry: Rajnish Retail Bags Rs1,500 Crore Order, Share Prices Predicted to Surge by 2,000%

New Delhi [India], January 17: Rajnish Retail Limited, a prestigious diamond and jewelry company based in Mumbai, has achieved a historic technical milestone. According to sources, this leading Indian company has secured a massive Rs1,500 crore order from two of the world's largest diamond companies, De Beers and Signet Jewelers. This deal is considered a significant achievement for the Indian company, likely to boost its market value and business substantially. Market analysts predict that the company's share price could witness a tremendous surge following this deal. They believe the share price could grow by approximately 2,000% in the next 10-12 months. Currently priced around Rs14, the share is expected to surpass Rs220 by next year.

Jan 17, 2025